| Literature DB >> 25255303 |
Hassan Yousefnia1, Samaneh Zolghadri2, Amir Reza Jalilian1, Mojtaba Tajik3, Mohammad Ghannadi-Maragheh1.
Abstract
In this work, the absorbed dose to each organ of human for (166)Ho-TTHMP was evaluated based on biodistribution studies in rats by a RADAR method and was compared with (166)Ho-DOTMP as the only clinically used Ho-166 bone marrow ablative agent. The highest absorbed dose for this complex is observed in red marrow with 0.922mGy/MBq. The results show that (166)Ho-TTHMP has considerable characteristics compared to (166)Ho-DOTMP and can be a good candidate for bone marrow ablation in patients with multiple myeloma.Entities:
Keywords: (166)Ho-TTHMP; Bone marrow ablation; Internal dosimetry; RADAR
Mesh:
Substances:
Year: 2014 PMID: 25255303 DOI: 10.1016/j.apradiso.2014.08.017
Source DB: PubMed Journal: Appl Radiat Isot ISSN: 0969-8043 Impact factor: 1.513